_image.png "Image: Through neoadjuvant therapy combining chemotherapy with immune checkpoint inhibitors (ICI) for 46 LAGC patients and single-cell transcriptome sequencing, researchers found that tumor cells in the treatment-sensitive group specifically upregulated MHC-II (tumor-specific major histocompatibility complex class II, tsMHC-II) molecules (photo courtesy of Science China Press)")
New
Gold Member
Aspiration System
VACUSAFE
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
HPV Molecular Test
BD Onclarity HPV Assay
In Other News
Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
ctDNA MRD Test Identifies Breast Cancer Patients Who May Avoid Surgery
WGS MCED Assay Demonstrates Rising Sensitivity and High Specificity
Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing
Blood-Based ctDNA Test Enhances Risk Assessment in HPV-Related Throat Cancer
International Consensus Standardizes Tumor Microbiota Detection and Reporting
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
RNA Profiling Uncovers Therapeutic Targets in Solid Tumors
Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample
AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample
Whole Genome Sequencing in Routine Care Expands Rare Disease Detection
New Bacterial Target Identified for Early Detection of Noma
AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer
New AI Tool Improves Detection of Genetic Causes in Rare Disorders
Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
Takara Bio USA and Hamilton Partner Partner to Automate NGS Library Preparation
AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer
Rapid Urine Test Speeds Antibiotic Selection for UTIs
AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer
Lunit and CellCarta Collaborate to Expand AI Pathology in CDx Development
New Molecular Test Boosts Accuracy of Bile Duct Cancer Diagnosis